Duration of untreated psychosis and clinical outcomes of first episode psychosis: An observational and an instrumental variables analysis.


Journal

Early intervention in psychiatry
ISSN: 1751-7893
Titre abrégé: Early Interv Psychiatry
Pays: Australia
ID NLM: 101320027

Informations de publication

Date de publication:
08 2019
Historique:
received: 10 11 2017
revised: 19 02 2018
accepted: 13 03 2018
pubmed: 27 4 2018
medline: 8 2 2020
entrez: 27 4 2018
Statut: ppublish

Résumé

Duration of untreated psychosis (DUP) is considered as a key prognostic variable in psychosis. Yet, it is unclear whether a longer DUP causes worse outcomes or whether reported associations have alternative explanations. Data from 2 cohorts of patients with first episode psychosis were used (n = 2134). Measures of DUP were assessed at baseline and outcomes at 12 months. Regression models were used to investigate the associations between DUP and outcomes. We also investigated whether any associations were replicated using instrumental variables (IV) analysis to reduce the effect of residual confounding and measurement bias. There were associations between DUP per 1-year increase and positive psychotic symptoms (7.0% in symptom score increase 95% confidence interval (CI) 4.0%, 10.0%, P < .001), worse recovery (risk difference [RD] 0.78, 95%, CI 0.68, 0.83, P < .001) and worse global functioning (0.62 decrease in functioning score 95% CI -1.19, -0.04, P = .035). There was no evidence of an association with negative psychotic symptoms (1.0%, 95%, CI -2.0%, 5.0%, P = .455). The IV analysis showed weaker evidence of associations in the same direction between DUP per 1-year increase and positive psychotic symptoms, recovery and global functioning. However, there was evidence of an inverse association with negative psychotic symptoms (decrease of 15.0% in symptom score 95% CI -26.0%, -3.0%, P = .016). We have confirmed previous findings of a positive association between positive psychotic symptoms, global functioning and recovery and DUP using regression analysis. IV analysis shows some support for these findings. Future investigation using IV analysis should be repeated in large data sets.

Identifiants

pubmed: 29696781
doi: 10.1111/eip.12676
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

841-847

Subventions

Organisme : Department of Health
ID : RP-PG-0109-10074
Pays : United Kingdom

Informations de copyright

© 2018 John Wiley & Sons Australia, Ltd.

Auteurs

Sarah A Sullivan (SA)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
NIHR CLAHRC West, Bristol, UK.

Robert Carroll (R)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Tim J Peters (TJ)

NIHR CLAHRC West, Bristol, UK.
School of Clinical Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Tim Amos (T)

Avon & Wiltshire Mental Health Partnership NHS Trust, Chippenham, UK.

Peter B Jones (PB)

Department of Psychiatry, University of Cambridge, Cambridge, UK.

Max Marshall (M)

Lancashire Care NHS Trust, Preston, UK.

Max Birchwood (M)

Mental Health and Wellbeing, Warwick Medical School, University of Warwick.

David Fowler (D)

School of Psychology, University of Sussex, Brighton, UK.

Sonia Johnson (S)

Division of Psychiatry, University College London, London, UK.
Camden and Islington NHS Foundation Trust, London, UK.

Helen L Fisher (HL)

King's College London, Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, London, UK.

Barnaby Major (B)

EQUIP, Hackney, East London NHS Foundation Trust, London, UK.
Herefordshire Early Intervention Service, 2gether NHS Foundation Trust, Gloucester, UK.

Nikola Rahaman (N)

Kensington, Chelsea, Westminster and Brent Early Intervention Service, Central & North West London NHS Foundation Trust, London, UK.

John Joyce (J)

Lewisham Early Intervention Service, South London and Maudsley NHS Foundation Trust, London, UK.

Nick Chamberlain-Kent (N)

Wandsworth Early Intervention Service, South West London & St Georges' Mental Health NHS Trust, London, UK.

Jo Lawrence (J)

STEP, Southwark, South London and Maudsley NHS Foundation Trust, London, UK.

Paul Moran (P)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Kate Tilling (K)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
NIHR CLAHRC West, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH